ArticleNeurologia medico-chirurgica2025
Efficacy of Step-down Infusion Method of a Novel Barbiturate Therapy for Severe Subarachnoid Hemorrhage with Intracerebral Hematoma.
Article in Neurologia medico-chirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Remote Ischemic Post-Conditioning Preserves the Neurovascular Unit by Brain-Derived Gas6 That Drives Monocyte-Derived Macrophage Reprogramming via Axl and Vimentin after SAH.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, there is no effective treatment for elevated intracranial pressure in the acute phase of subarachnoid hemorrhage. Recently, we developed "step-down infusion of barbiturate," a therapeutic strategy for severe traumatic brain injury, which decreased intracranial pressure and significantly reduced mortality without serious side effects. This study aimed to examine the efficacy of step-down infusion of barbiturate in patients with severe subarachnoid hemorrhage. Of the 342 patients with subarachnoid hemorrhage treated surgically at our hospital from January 2010 to May 2022, 17 with ruptured middle cerebral artery aneurysms and intracerebral hematoma graded as World Federation of Neurosurgical Societies Grade IV or V underwent hematoma removal, aneurysmal clipping or coiling, and external decompression. These patients were divided into 2 groups: the step-down infusion of barbiturate group and the control group, which was treated without step-down infusion of barbiturate. Thiamylal sodium was initiated immediately after surgery at 4 mg/kg/h and tapered to 3, 2, 1.5, and 1 mg/kg/h every 24 hrs after the start of normothermia administration. We evaluated the modified Rankin scale and Extended Glasgow Outcome Scale scores 1 year after admission. The step-down infusion of barbiturate group showed significantly better outcomes and well-controlled intracranial pressure (<20 mm Hg); moreover, cerebral perfusion pressure was maintained above 50 mm Hg, and there were no deaths or serious side effects associated with barbiturate use. Our novel method of prophylactic step-down infusion of barbiturate with normothermia for severe subarachnoid hemorrhage can safely lower intracranial pressure while maintaining cerebral perfusion pressure without serious side effects. This method may improve the outcomes in severe subarachnoid hemorrhage with intracerebral hematoma, although further studies are needed to confirm its efficacy and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.